30-Days Cardiovascular In-Hospital Mortality After Heart Valve Intervention: A Real-World Data Analysis in Italy

Author(s)

Sciattella P, Mennini FS
Economic Evaluation and HTA (EEHTA CEIS), Department of Economics and Finance, Faculty of Economics, University of Rome “Tor Vergata”, Rome, Italy

Presentation Documents

OBJECTIVES:

To estimate 30-day cardiovascular in-hospital mortality (CIHM) in patients who underwent heart valve surgery versus transcatheter therapy, using the Hospital Information System (HIS) of Italy.

METHODS:

From HIS, which collects information related to all discharges from public and private hospitals in Italy, we identified all patients aged ≥18 years undergoing single heart valve intervention (aortic/AV-population or mitral/MV-population) between January 2017 and November 2018.

For patients with multiple hospital admissions, only the first one was considered (index-event).

According to the type of intervention, subjects were classified into two groups: traditional surgery (TS) and transcatheter approach (TA).

30-day CIHM was evaluated considering index and subsequent hospitalizations with main diagnosis of circulatory system diseases.

Patient clinical history was defined by retrieving comorbidities recorded during hospitalizations

in the 2 years before the index-event.

The association between intervention and outcome was assessed using logistic models [Odds Ratio (OR)] and adjusting for age, sex and the risk factors selected by a stepwise bootstrap procedure.

RESULTS:

37,687 subjects were selected for AV-population (58.2% men, mean age 72.6 years): 29,004 (77.0%) undergoing TS and 8,683 (23.0%) TA.

30-day CIHM was 3.3% for TS patients and 2.2% for TA patients, (OR 0.64; 95%CI 0.55-0.75). Multivariate analysis confirmed a reduction of mortality for patients undergoing TA (ORadj 0.52; 95%CI 0.43-0.61).

For MV-population, 15,340 patients were identified (60.0% men, mean age 65.5 years), of whom 13,711 (89.4%) undergoing TS surgery and 1,629 (10.6%) TA.

A reduction of 30-day CIHM for TA patients (2.3% vs 3.3%) was confirmed in both the univariate (OR 0.71; 95%CI 0.50-0.98) and multivariate model (ORadj 0.50; 95%CI 0.35‑0.70).

CONCLUSIONS:

The study, based on Italian administrative databases, allowed to estimate the in-hospital mortality for patients with aortic and mitral heart valve disorders, highlighting a significant association between outcome and treatment strategy.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark

Value in Health, Volume 24, Issue 12, S2 (December 2021)

Code

POSB406

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Cardiovascular Disorders, Surgery

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×